Signaturefd, LLC Xeris Biopharma Holdings, Inc. Transaction History
Signaturefd, LLC
- $5.4 Billion
- Q2 2025
A detailed history of Signaturefd, LLC transactions in Xeris Biopharma Holdings, Inc. stock. As of the latest transaction made, Signaturefd, LLC holds 631 shares of XERS stock, worth $3,300. This represents 0.0% of its overall portfolio holdings.
Number of Shares
631
Previous 391
61.38%
Holding current value
$3,300
Previous $2,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding XERS
# of Institutions
205Shares Held
84.7MCall Options Held
132KPut Options Held
69.4K-
Black Rock Inc. New York, NY10.3MShares$54 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.11MShares$42.4 Million0.0% of portfolio
-
Morgan Stanley New York, NY4.29MShares$22.4 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.41MShares$17.8 Million0.0% of portfolio
-
State Street Corp Boston, MA3.33MShares$17.4 Million0.0% of portfolio
About Xeris Biopharma Holdings, Inc.
- Ticker XERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,956,992
- Market Cap $711M
- Description
- Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...